Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer
Abstract Heparanase promotes tumor growth in breast tumors. We now evaluated heparanase protein and gene-expression status and investigated its impact on disease-free survival in order to gain better insight into the role of heparanase in ER-positive (ER+) breast cancer prognosis and to clarify its...
Guardado en:
Autores principales: | Tamar Zahavi, Mali Salmon-Divon, Roberto Salgado, Michael Elkin, Esther Hermano, Ariel M. Rubinstein, Prudence A. Francis, Angelo Di Leo, Giuseppe Viale, Evandro de Azambuja, Lieveke Ameye, Christos Sotiriou, Asher Salmon, Nataly Kravchenko-Balasha, Amir Sonnenblick |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/637b2a9596934ef69ef658839f8718ad |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Role of Heparanase in the Pathogenesis of Acute Pancreatitis: A Potential Therapeutic Target
por: Iyad Khamaysi, et al.
Publicado: (2017) -
Epigenetic signature of chronic low back pain in human T cells
por: Stéphanie Grégoire, et al.
Publicado: (2021) -
Serum Heparanase: A New Clinical Biomarker Involved in Senile Metabolic Inflammatory Syndrome
por: Zhou X, et al.
Publicado: (2021) -
The more you give, the worse it gets
por: Sze Shyang Kho, et al.
Publicado: (2021) -
Heparanase inhibition preserves the endothelial glycocalyx in lung grafts and improves lung preservation and transplant outcomes
por: Kentaro Noda, et al.
Publicado: (2021)